Recombinant multi-species CCL26 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL26 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is one of two Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 7. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for normal peripheral blood eosinophils and basophils. This protein also has antimicrobial activity, displaying an antibacterial effect on S. pneumoniae, S. aureus, Non-typeable H. influenzae, and P. aeruginosa. The product of this gene is one of three related chemokines that specifically activate chemokine receptor CCR3. This chemokine may contribute to the eosinophil accumulation in atopic diseases. [provided by RefSeq, Jul 2020]
The Alternative Names of target: C-C motif chemokine 26,CC chemokine IMAC,CCL26,Ccl26,Ccl26l,Eotaxin-3,IMAC,MIP-4a,MIP-4alpha,Macrophage inflammatory protein 4-alpha (MIP-4-alpha),SCYA26,Small-inducible cytokine A26,TSC-1,Thymic stroma chemokine-1 (TSC-1)

Target products collectionGo to CCL26 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0746-Ag-1/ GM-Tg-hg-SE0746-Ag-2 Human CCL26 protein Human
GM-Tg-rg-SE0746-Ag-1/ GM-Tg-rg-SE0746-Ag-2 Rat CCL26 protein Rat
GM-Tg-mg-SE0746-Ag-1/ GM-Tg-mg-SE0746-Ag-2 Mouse CCL26 protein Mouse
GM-Tg-cynog-SE0746-Ag-1/ GM-Tg-cynog-SE0746-Ag-2 Cynomolgus/Rhesus macaque CCL26 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0746-Ag-1/ GM-Tg-felg-SE0746-Ag-2 Feline CCL26 protein Feline
GM-Tg-cang-SE0746-Ag-1/ GM-Tg-cang-SE0746-Ag-2 Canine CCL26 protein Canine
GM-Tg-bovg-SE0746-Ag-1/ GM-Tg-bovg-SE0746-Ag-2 Bovine CCL26 protein Bovine
GM-Tg-equg-SE0746-Ag-1/ GM-Tg-equg-SE0746-Ag-2 Equine CCL26 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0746-Ag-1/ GM-Tg-hg-SE0746-Ag-2; GM-Tg-rg-SE0746-Ag-1/ GM-Tg-rg-SE0746-Ag-2;
GM-Tg-mg-SE0746-Ag-1/ GM-Tg-mg-SE0746-Ag-2; GM-Tg-cynog-SE0746-Ag-1/ GM-Tg-cynog-SE0746-Ag-2;
GM-Tg-felg-SE0746-Ag-1/ GM-Tg-felg-SE0746-Ag-2; GM-Tg-cang-SE0746-Ag-1/ GM-Tg-cang-SE0746-Ag-2;
GM-Tg-bovg-SE0746-Ag-1/ GM-Tg-bovg-SE0746-Ag-2; GM-Tg-equg-SE0746-Ag-1/ GM-Tg-equg-SE0746-Ag-2
Products Name CCL26 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CCL26
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL26 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.